Results for tag: "Varicella Live Vaccine"

The Varicella Live Vaccine is a vaccine used to prevent varicella, also known as chickenpox. It is a live attenuated vaccine, meaning it contains a weakened form of the virus. The vaccine is typically given to children between the ages of 12 and 15 months, with a booster dose recommended between the ages of 4 and 6 years. It is also recommended for adults who have not had chickenpox or the vaccine. The vaccine is generally well-tolerated, with mild side effects such as redness, swelling, and soreness at the injection site. The Varicella Live Vaccine market is a subset of the larger Vaccines market. It is a growing market, with increasing demand for the vaccine due to its effectiveness in preventing varicella. The market is highly competitive, with several companies offering the vaccine. Some companies in the Varicella Live Vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and AstraZeneca. Show Less Read more